TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 142 filers reported holding TRILLIUM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $51,318,000 | -9.7% | 5,290,481 | 0.0% | 0.82% | -3.9% |
| Q1 2021 | $56,820,000 | -27.0% | 5,290,481 | 0.0% | 0.86% | -21.2% |
| Q4 2020 | $77,823,000 | -11.1% | 5,290,481 | -14.2% | 1.09% | -32.1% |
| Q3 2020 | $87,572,000 | +75.6% | 6,162,694 | 0.0% | 1.60% | +64.8% |
| Q2 2020 | $49,856,000 | +94.0% | 6,162,694 | -3.1% | 0.97% | +19.7% |
| Q1 2020 | $25,700,000 | – | 6,361,446 | – | 0.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|